New insider activity at Pitney Bowes ( (PBI) ) has taken place on November 4, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director Peter C. Brimm has made a significant investment in Pitney Bowes by purchasing 12,500 shares of the company’s stock, with the transaction valued at $126,993.
Recent Updates on PBI stock
In the last 24 hours, Pitney Bowes has been the focus of several financial analyses following its Q3 earnings report. Goldman Sachs initiated coverage with a Neutral rating, citing the company’s balance between its transformation strategy and the ongoing decline in mailing services. Despite reporting a revenue decline to $459.7 million from $499.463 million last year, Pitney Bowes showed improved earnings with a GAAP EPS of $0.30 and an adjusted EPS of $0.31. The company is actively pursuing strategic initiatives such as a $161 million share repurchase program and a cost reduction plan aiming to save $50 to $60 million by 2026. These moves underscore confidence in long-term growth despite current challenges, including forecasting issues and revenue declines in the Presort segment. The company expects to meet the lower end of its revenue, EBIT, and free cash flow guidance, while aiming for the midpoint of its adjusted EPS guidance.
Spark’s Take on PBI Stock
According to Spark, TipRanks’ AI Analyst, PBI is a Neutral.
Pitney Bowes’ overall stock score is primarily impacted by its financial performance challenges, including high leverage and declining profitability. Technical indicators suggest bearish momentum, while valuation metrics provide limited upside. The earnings call offers some optimism with strategic initiatives, but immediate financial results remain under pressure.
To see Spark’s full report on PBI stock, click here.
More about Pitney Bowes
YTD Price Performance: 38.65%
Average Trading Volume: 3,081,070
Technical Sentiment Signal: Buy
Current Market Cap: $1.58B

